22
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A Phase II Study with CPT-11 Plus Leucovorin and Bolus IV 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma

, Ph.D. , M.D., , M.D., , M.D., , M.D., , Ph.D. , M.D., , M.D., , M.D., , M.Sc., , M.D., , M.D. & , M.D. show all
Pages 855-862 | Published online: 12 Oct 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

C. Gennatas, G. Papaxoinis, V. Michalaki, D. Mouratidou, CH. Andreadis, N. Tsavaris & A. Pafiti. (2006) A Prospective Randomized Study of Irinotecan (CPT-11), Leucovorin (LV) and 5-Fluorouracil (5FU) versus Leucovorin and 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma. Journal of Chemotherapy 18:5, pages 538-544.
Read now

Articles from other publishers (4)

Christos A Papadimitriou, Pavlos Papakostas, Maria Karina, Lia Malettou, Meletios A Dimopoulos, George Pentheroudakis, Epaminontas Samantas, Aristotelis Bamias, Dimosthenis Miliaras, George Basdanis, Nikolaos Xiros, George Klouvas, Dimitrios Bafaloukos, Georgia Kafiri, Irene Papaspirou, Dimitrios Pectasides, Charisios Karanikiotis, Theofanis Economopoulos, Ioannis Efstratiou, Ippokratis Korantzis, Nikolaos Pisanidis, Thomas Makatsoris, Fotini Matsiakou, Gerasimos Aravantinos, Haralabos P Kalofonos & George Fountzilas. (2011) A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study. BMC Medicine 9:1.
Crossref
H.P. Kalofonos, A. Bamias, A. Koutras, P. Papakostas, G. Basdanis, E. Samantas, M. Karina, D. Misailidou, N. Pisanidis, G. Pentheroudakis, T. Economopoulos, C. Papadimitriou, D.V. Skarlos, D. Pectasides, M. Stavropoulos, D. Bafaloukos, D. Kardamakis, C. Karanikiotis, G. Vourli & G. Fountzilas. (2008) A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study. European Journal of Cancer 44:12, pages 1693-1700.
Crossref
H.P. Kalofonos, G. Aravantinos, P. Kosmidis, P. Papakostas, T. Economopoulos, M. Dimopoulos, D. Skarlos, A. Bamias, D. Pectasides, S. Chalkidou, M. Karina, A. Koutras, E. Samantas, C. Bacoyiannis, G.F. Samelis, G. Basdanis, F. Kalfarentzos & G. Fountzilas. (2005) Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Annals of Oncology 16:6, pages 869-877.
Crossref
Bengt Glimelius. (2005) Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer. Drug Safety 28:5, pages 417-433.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.